↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

34 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Acitretin   Acitretin   D02754   4件: RARA, RXRA, RXRB, RXRG   1件: Th17 cell differentiation   1件:
37 
 2   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 3   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 4   Alefacept   Alefacept   D02800   1件: CD58   1件: Cell adhesion molecules (CAMs)   6件:
37,
60,
65,
164,
284,
285 
 5   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 6   Anb019   -   -   -   -   1件:
37 
 7   Bi 655130   -   -   -   -   3件:
37,
96,
97 
 8   Bi655130   -   -   -   -   1件:
37 
 9   Brodalumab   Brodalumab   D10061   1件: IL17RA   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   2件:
37,
51 
 10   Calcitriol   Calcitriol   D00129   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 11   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 12   Efalizumab   Efalizumab   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   8件:
11,
13,
37,
46,
53,
61,
95,
96 
 13   Guselkumab   Guselkumab   D10438   1件: IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   3件:
37,
96,
97 
 14   Guselkumab 100 mg   Guselkumab   D10438   1件: IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
37 
 15   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 16   Infliximab [infliximab biosimilar 3]   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   4件:
37,
46,
96,
97 
 17   Ixekizumab   Ixekizumab   D10071   1件: IL17A   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   4件:
37,
162,
269,
271 
 18   Khk4827   -   -   -   -   2件:
37,
51 
 19   Khk4827 140mg sc   -   -   -   -   1件:
37 
 20   Khk4827 210mg sc   -   -   -   -   1件:
37 
 21   Monoclonal antibody anti-igg1   -   -   -   -   3件:
37,
96,
97 
 22   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 23   P32   Phosphorus P-32   -   -   -   1件:
37 
 24   P32/98   Phosphorus P-32   -   -   -   1件:
37 
 25   P32/98 3%   Phosphorus P-32   -   -   -   1件:
37 
 26   Raptiva   Efalizumab   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   3件:
37,
49,
53 
 27   Risankizumab   Risankizumab   D11052   1件: IL23A   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Th17 cell differentiation   4件:
37,
96,
97,
271 
 28   Secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   7件:
13,
37,
41,
46,
160,
269,
271 
 29   Secukinumab 150mg   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   2件:
37,
271 
 30   Secukinumab 300mg   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
37 
 31   Silikis 3µg/g salbe   -   -   -   -   1件:
37 
 32   Spesolimab   -   -   -   -   3件:
37,
96,
97 
 33   Ta-650   -   -   -   -   4件:
37,
56,
96,
97 
 34   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 

先頭へ